APA (7th ed.) Citation

Kozubík, A., Kleban, J., Kovaľ, J., Fedoročko, P., Solár, P., Horváth, V., & Solárová, Z. Hsp90 inhibitor Geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin.

Chicago Style (17th ed.) Citation

Kozubík, A., J. Kleban, J. Kovaľ, Peter Fedoročko, Peter Solár, V. Horváth, and Z. Solárová. Hsp90 Inhibitor Geldanamycin Increases the Sensitivity of Resistant Ovarian Adenocarcinoma Cell Line A2780cis to Cisplatin.

MLA (9th ed.) Citation

Kozubík, A., et al. Hsp90 Inhibitor Geldanamycin Increases the Sensitivity of Resistant Ovarian Adenocarcinoma Cell Line A2780cis to Cisplatin.